Kátia Nunes da Silva

Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?

C. Nonaka, B. R. Cavalcante, P. Rocco, 2021, Stem cell research & therapy.

Generation of human iPS cell line CBTCi001-A from dermal fibroblasts obtained from a healthy donor.

C. Nonaka, B. Souza, R. D. dos Santos, 2019, Stem cell research.

Generation of integration-free iPS cell lines from three sickle cell disease patients from the state of Bahia, Brazil.

C. Nonaka, B. R. Cavalcante, B. Souza, 2018, Stem cell research.

Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.

F. Tavora, R. H. Carvalho, B. Souza, 2017, The American journal of pathology.

Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report

C. Nonaka, B. Souza, B. Andrade, 2021, Frontiers in Medicine.